Needham Downgrades Hologic Ahead of COVID-19 Testing Decline
November 20, 2020 at 07:38 AM EST
Needham analyst Mike Matson downgraded Hologic to Hold from Buy without a price target.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|